Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index; 9 of the 22 sources its claims cite were checked for support.

Albendazole-induced granulomatous hepatitis: a case report

Open access
Marin Zuluaga, Juan Ignacio, Marin Castro, Andres Eduardo, Perez Cadavid, Juan Camilo, Restrepo Gutierrez, Juan Carlos · 2013 · Journal of Medical Case Reports

Abstract

Case report of albendazole-induced granulomatous hepatitis diagnosed after exclusion of other causes and improvement after withdrawal.

Overview

CoChat Summary

TL;DR

This case report describes a 25-year-old Hispanic woman with acute hepatitis of unknown etiology who was diagnosed with albendazole-induced granulomatous hepatitis after other causes were excluded and her liver profile improved after drug withdrawal. The CIOMS-RUCAM score was 5 (“possible”), and liver biopsy showed non-necrotizing epithelioid granulomas.

Key findings

  • A 25-year-old Hispanic woman presented with progressive jaundice, right upper quadrant pain, fatigue, weakness, and dark urine, without acholia, fever, or vomiting; liver and biliary ultrasonography were normal.
  • Liver biopsy showed portal inflammatory infiltrate of lymphocytes, plasma cells, and neutrophils, hepatocyte necrosis of the limiting plate, and macrophage infiltrate with non-necrotizing epithelioid granulomas in the hepatic sinusoids; special stains for tuberculosis and fungi were negative, and chest/abdomen CT was normal.
  • Detailed drug history revealed albendazole, paracetamol, and hyoscine butyl bromide 2 weeks before jaundice; after medication withdrawal, the patient had gradual normalization of liver biochemical profile without specific treatment, with follow-up at 2 and 6 months showing spontaneous resolution.
  • The CIOMS-RUCAM scale showed a “possible” relationship with a score of 5; the paper also notes that in clinical trials albendazole was associated with mild to moderate liver enzyme elevations in about 16% of patients, and up to 17% of acute liver failure cases are attributed to idiosyncratic reactions.

Methods

  • Single case report of one 25-year-old Hispanic woman admitted to a Clinical Hepatology Unit with symptoms of acute hepatitis of unknown etiology.
  • Diagnostic workup included laboratory studies, liver and biliary ultrasonography, percutaneous ultrasound-guided liver biopsy, special stains for tuberculosis and fungi, contrasted CT of the chest and abdomen, stool specimen, detailed drug history, and CIOMS-RUCAM causality assessment.
  • Main analysis was descriptive: exclusion of other possible causes, histologic pattern, drug history, and spontaneous improvement after medication withdrawal.

Limitations

  • The paper states that diagnosis of drug-induced liver injury is one of exclusion, with no absolute criteria or specific method, heterogeneous clinical presentation and evolution, poorly understood risk factors and pathogenesis, and no models for predicting adverse reactions.
  • The paper reports a CIOMS-RUCAM score of 5 (“possible”), not a higher category, and notes that only three articles were indexed in MEDLINE at the time of review.
  • Evident from the text: this is a single-patient case report without a control or rechallenge, so it cannot establish incidence or causality beyond this patient.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/1752-1947-7-201

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Hematoxylin and eosin stain. Portal tracts infiltrate with moderate and mixed inflammation, consisting of lymphocytes, plasma cells, neutrophils, and eosinophils with moderate interface activity. Inflammatory Activity Grade 3 to 4.
Figure 1 Hematoxylin and eosin stain. Portal tracts infiltrate with moderate and mixed inflammation, consisting of lymphocytes, plasma cells, neutrophils, and eosinophils with moderate interface activity. Inflammatory Activity Grade 3 to 4.CC BY · PubMed Central
Figure 2 Hematoxylin and eosin stain. Hepatic parenchyma with presence of epithelioid macrophages that have formed granulomas without necrosis, interspersed with lymphocytes. Inflammatory activity around the granulomas is characterized by inflammatory lobular cells between the sinusoids and hepatocytes.
Figure 2 Hematoxylin and eosin stain. Hepatic parenchyma with presence of epithelioid macrophages that have formed granulomas without necrosis, interspersed with lymphocytes. Inflammatory activity around the granulomas is characterized by inflammatory lobular cells between the sinusoids and hepatocytes.CC BY · PubMed Central

Verification

Claims the paper makes

6 Valid · 1 Not valid · 5 Not checked · 16 Own results and interpretations

3 more claims

Create a free account to see all 28 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 13
  • Probably not a substantial claim. 12

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 14 references

Research works printed but not linked: 1

  1. Fernandez MR, Riesco JM, Moreira VF, Moreno A, San Roman AL, Arranz G, Ruiz Del Arbol L: Recurrent hepatic toxicity secondary to intravenous methylprednisolone. Rev Esp Enferm Dig. 2008, 100 (11): 720-723.

Cited by

See all 45

Metadata

Authors
Marin Zuluaga, J. I., Marin Castro, A. E., Perez Cadavid, J. C., & Restrepo Gutierrez, J. C.
Venue
Journal of Medical Case Reports
Published
2013-07-26
Volume
7
Issue
1
Pages
201-201
ISSN
1752-1947 (ISSN-L)
OpenAlex
W2154715170
Cited by
45
References
14
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 6 · 2020: 2 · 2019: 2 · 2018: 6 · 2017: 6 · 2015: 1 · 2014: 4 · 2013: 1
FWCI
2.18
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • Journal of Medical Case Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repository University of Antioquia (University of Antioquia) (submittedVersion, cc-by-nc)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
albendazole, drug-induced liver injury, granulomatous hepatitis, hepatotoxicity, liver biopsy, drug withdrawal, RUCAM, acute hepatitis, antiparasitic drugs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Albendazole-induced granulomatous hepatitis: a case report. https://app.cochat.ai/papers/10.1186/1752-1947-7-201
The paper
Marin Zuluaga, J. I., Marin Castro, A. E., Perez Cadavid, J. C., & Restrepo Gutierrez, J. C. (2013). Albendazole-induced granulomatous hepatitis: a case report. Journal of Medical Case Reports. https://doi.org/10.1186/1752-1947-7-201

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.